ICON plc | Clinical Research Organisation (CRO) for Drug Development

Complexity and declining ROI in drug development

Perspectives from senior pharma executives.

Payers’ Perspectives on Digital Therapeutics

Using technology advancements for powerful real world evidence.

How digital technologies will transform R&D productivity

Transforming pharma operating models through emerging digital technologies.

Reimagining Patient-Centric clinical trials with the IoMT

Discover how emerging technologies can increase clinical trial efficiency.

Featured Services

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biosimilars

ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

31 March 2020

Parkinson’s disease clinical trials: Challenges and the role of technology

The human brain is probably the most complex structure in the universe. It is therefore not surprising that clinical trials for CNS diseases pose various challenges.

27 March 2020

Managing trial participants with cardiovascular and metabolic disease during COVID-19

The COVID-19 pandemic is of particular concern for cardiovascular and metabolic trials because the subjects recruited are typically older with underlying cardiovascular disease and/or diabetes.

26 March 2020

Digital intelligence for the clinical trial: How the IoMT is streamlining clinical operations

Rapid progress in connectivity and technology is inspiring innovative clinical trial design.

19 March 2020

COVID-19, Influenza and cardiovascular disease - What is known?

Increasing evidence supports that influenza infections can be a trigger for acute myocardial infarction (AMI) and stroke.

13 March 2020

Preparing for Disease X, a look at the potential impact of Coronavirus

The international response to Coronavirus is focused on a number of key steps; containing the disease, saving the lives of those infected and developing vaccines.

23 January 2020

Immunotherapy in Cancer Treatment

Immunotherapy has been the focus of medical research for many years, and scientists continue to experiment with and learn about the form of therapy in cancer treatment.

14 January 2020

Changes in clinical safety reporting to the FDA

FDA has upgrade the Investigational New Drug (IND) safety reporting from paper eCTD format to E2B format, improving potential safety signals in clinical studies.

03 December 2019

Healthcare Resource Use and Costs in AML Patients

The objective of this study was to estimate the cost of treatment-resource use and costs associated with sick leave (SL) and early retirement (ER) in patients below the age of 60 years with AML.

27 November 2019

Innovation in Oncology Drug Development

Significant progress has been made in our understanding of the molecular lesions responsible for tumor cells to exhibit uncontrolled growth.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

COVID-19 clinical operations

Coronavirus Observatory

Outsourced Pharmacovigilance Affiliate Solution.

Decentralised and Hybrid Trials.